Navigation Links
Advanced Life Sciences Announces Second Quarter 2008 Financial Results
Date:8/14/2008

those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of our estimates regarding expenses, future revenues and capital requirements; our ability to obtain financing on terms acceptable to us; our ability to obtain and maintain intellectual property protection for our product candidates; the successful development of our sales and marketing capabilities; the success of competing drugs that become available; and the performance of third party collaborators and manufacturers. These and additional risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.

ADVANCED LIFE SCIENCES HOLDINGS, INC. AND SUBSIDIARY

(A Development Stage Company)

June 30, December 31,

CONSOLIDATED BALANCE SHEETS 2008 2007

(Unaudited)

ASSETS

CURRENT ASSETS:

Cash and cash equivalents $9,054,421 $18,324,991

Prepaid insurance 48,527 251,493

Prepaid clinical trial expenses - 926,168

Other prepaid expenses and deposits 89,360 140,359

Total current assets 9,192,308 19,643,011

PROPERTY AND EQUIPMENT:

Furniture and fixtures 232,461 221,417

Laboratory equipment 159,186 159,186

Computer software and equipment 250,104 242,707

Leasehold improvements 502,798 177,253

Total property and

equipment - at cost 1,144,549 800,563

Less accumulated depreciation (659,108) (542,032)

Property and equipment - net 485,441
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Toronto, Canada (PRWEB) July 10, 2014 ... often present in very low abundance and are ... quite challenging and time-consuming. , Join presenters Dr. ... Laboratories, and Dr. John Anders, Head of Quality ... mass spectrometer-based approach that can speed detection and ...
(Date:7/10/2014)... 10, 2014 Unraveling life’s mysteries can ... The Archer Family purchased a DNA test ... ended up with a lifetime of memories, sharing, and ... family members’ DNA genuinely brought the family closer together. ... deeper into genetic history and prior to taking the ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Senior ... institutions and professional associations, addressed the challenges of “Reducing ... Medical Device Industries” through strategic sourcing. Describing the partnership ... with the Supply Chain Management Institute ( SCMI) ... event on June 24 at the Kroc Institute of ...
(Date:7/10/2014)... PROVO, Utah , July 10, 2014 ... genome annotation and interpretation, today announced an ... sequencing (NGS) analytics for Lineagen,s NextStep Dx ... evaluation of neurodevelopmental and neurological disorders, currently ... chromosomal microarray (CMA) testing service used by ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... Quark Pharmaceuticals, Inc.,a development-stage pharmaceutical company ... therapeutics, today announced the,presentation of posters ... taking place,September 16-18, 2008 in Stockholm, ... Hagar Kalinski, and Hagit Ashush, presented ...
... 17 Dendreon Corporation,(Nasdaq: DNDN ) today announced ... of Dendreon, will present a company update at the,UBS ... Monday, September,22, 2008 at 1:30 p.m. ET., A ... through the,Investor Relations section of the Dendreon website, http://www.dendreon.com ...
... China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, ... the "Company"), one of the leading plasma-based ... ("PRC"), today announced that the Company,received approval ... Administration (the,"SFDA") to commence clinical trial of ...
Cached Biology Technology:Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008 2Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008 3China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII 2China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII 3
(Date:7/10/2014)... , July 8, 2014 ... won a new design win (DW). An Asian OEM has ... for mass production start in August 2014.   ... smartphone OEM, which has a planned date for start of ... initial ramp order of SEK 5M, for delivery in the ...
(Date:7/10/2014)... Axinaea belongs to the large, mainly tropical flowering ... 5000 species in the family rely on bees for their ... other insects or vertebrates. The flowers of Axinaea ... and the petals of the different species are pink, yellow, ... based on the contrasting colours of their bulbous appendages. The ...
(Date:7/10/2014)... soap might not be ape friendly, and the situation appears ... the Cell Press journal Current Biology on July ... led to the conversion of Southeast Asian forest into oil ... are not put in place very soon, researchers say the ... will be bad news for great apes there as well. ...
Breaking Biology News(10 mins):FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2Novel type of bird pollination mechanism discovered in South America 2Hunger for vegetable oil means trouble for Africa's great apes 2
... increase in the number of infections with a specific ... Salmonella serovar Typhimurium DT104, is resistant to at least ... genetic information in DNA of DT104 that might be ... information might also be involved in the increase in ...
... clinical trials, coronary artery bypass surgery performed on a beating ... safe option that leads to fewer negative side effects for ... Surgery. , “Previously, it was more common for doctors ... the heart and passing the blood through a heart-lung machine,?says ...
... key enzyme can soothe over-excited receptors in the brain, ... Alzheimer's and other neurodegenerative diseases. , Lead author Michel ... student Wei Xu and collaborators from the University of ... issue of Neuron. , The researchers injected ...
Cached Biology News:Salmonella survives better in stomach due to altered DNA 2Decoy pill saves brain cells 2
... Z-Competent E. coli Transformation Buffer Set are ... E. coli cells for simple and highly ... eliminates the requirement for heat shocking and ... be performed by adding DNA to Z-Competent ...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
Apoptosis Detection Systems and Reagents...
Biology Products: